Researchers load CAR T cells with oncolytic virus to treat solid cancer tumors
Researchers have devised an immunotherapy technique that combines chimeric antigen receptor-T cell therapy, or CAR-T cell therapy, with a cancer-killing virus to more effectively target and treat solid cancer tumors.
Materials provided by Mayo Clinic. Original written by Susan Murphy. Note: Content may be edited for style and length.
Source link aaaaa